Efficacy and Safety of Lacosamide in the Treatment of Children with Epilepsy

Yu Jing; Zhao Ting; Li Hongjian; Ma Long; Sun Yan

doi:10.13407/j.cnki.jpp.1672-108X.2022.05.009

您当前的位置：

首页 >

文章列表页 >

Efficacy and Safety of Lacosamide in the Treatment of Children with Epilepsy

更新时间：2022-06-10

- Efficacy and Safety of Lacosamide in the Treatment of Children with Epilepsy
- Vol. 28, Issue 5, Pages: 32-35(2022)
- 作者机构：
  
  1. 新疆维吾尔自治区人民医院,乌鲁木齐,830000
  2. 新疆维吾尔自治区儿童医院,乌鲁木齐,830000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2022.05.009
  CLC：
- Published：2022，
扫描看全文
Yu Jing, Zhao Ting, Li Hongjian, et al. Efficacy and Safety of Lacosamide in the Treatment of Children with Epilepsy. [J]. 28(5):32-35(2022)
DOI：

Yu Jing, Zhao Ting, Li Hongjian, et al. Efficacy and Safety of Lacosamide in the Treatment of Children with Epilepsy. [J]. 28(5):32-35(2022) DOI： 10.13407/j.cnki.jpp.1672-108X.2022.05.009.

摘要

目的：评价拉考沙胺（LCM）在儿童癫痫的应用价值。方法：采用回顾性研究方法，对诊断为癫痫并接受LCM治疗的58例患儿进行分析。记录开始LCM治疗后3个月、6个月和12个月的癫痫发作频率，并与基线月度频率进行比较，评价患儿的临床疗效并观察不良反应。结果：患儿维持期LCM用量2.82~20.00（7.03±2.90）mg/（kg·d）。末次就诊40例（69.0%）患儿对LCM治疗有反应，表现出癫痫发作频率减少≥50%。癫痫完全控制率随着时间的推移而增加，在3、6、12个月时分别为15.5%、20.7%、24.1%。无效组异常脑电图患儿比例高于有效组（P均<0.05）。联合使用抗癫痫药物的数量越少，LCM添加得越早，儿童实现癫痫完全缓解的可能性就越高（P<0.05）。20例（34.5%）患儿至少经历了1次不良反应，常见不良反应为头晕、嗜睡、乏力和恶心呕吐。结论：LCM治疗癫痫发作患儿临床有效，且不良反应轻，耐受性好。

Abstract

Objective: To evaluate the clinical efficacy and safety of lacosamide (LCM) in the treatment of children with epilepsy. Methods: Fifty-eight children diagnosed with epilepsy and treated with LCM were retrospectively analyzed. The epilepsy frequencies of 3 months

6 months and 12 months after the start of LCM treatment were recorded and compared with the baseline monthly frequency. The clinical efficacy and adverse drug reactions were evaluated. Results: The dosage of LCM during the maintenance period was from 2.82 to 20.00 (7.03±2.90) mg/(kg·d). Forty children (69.0%) at the last visit responded to LCM treatment

demonstrating more than or equal to 50% reduction in epilepsy frequencies. The rate of complete control of epilepsy increased over time

respectively 15.5%

20.7% and 24.1% at 3

6 and 12 months. The proportion of abnormal electroencephalogram in the ineffective group was significantly higher than that in the effective group (P<0.05). The less the number of combined use of anti-seizure medications and the earlier the addition of LCM

the higher the possibility of complete remission of epilepsy (P<0.05). Twenty (34.5%) children had at least one adverse drug reaction

and the common adverse drug reactions were dizziness

somnolence

fatigue and nausea and vomiting. Conclusion: LCM is clinically effective in the treatment of children with epilepsy

with mild adverse drug reactions and good tolerance.

关键词

拉考沙胺癫痫儿童有效性安全性

Keywords

lacosamideepilepsychildrenefficacysafety

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Systematic Review on Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metabolic Disordersin Children

Factors Affecting Steady-State Plasma Concentration of Lacosamide in Children with Epilepsy in Xinjiangand Preliminary Establishment of Reference Range

Efficacy of 2% Crisaborole Ointment in the Treatment of Mild to Moderate Atopic Dermatitis in Children

Safety Analysis of Thalidomide in Systemic Juvenile Idiopathic Arthritis

Efficacy and Safety of Tanreqing Injection in the Treatment of Children with Viral Pneumonia: a Meta-Analysis

Related Author

Ren Danyang

Yang Yanming

Tu Caixia

Lyu Mengwei

Shen Jianling

Liu Yan

Li Yunwei

Li Huiying

Related Institution

Kunming Children’s Hospital / Children’s Hospital of Kunming Medical University, Kunming

Kunming MedicalUniversity, Kunming

Children’s Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Hospital of Beijing Children’s Hospital, Urumqi

Wuxi Children’s Hospital

Shanghai Children’s Hospital, Children’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

⁰